| Autor: |
PETROU, ILYA |
| Předmět: |
|
| Zdroj: |
Dermatology Times; Feb2020, Vol. 41 Issue 2, p31-31, 1p |
| Abstrakt: |
The article discusses a study which found that gene expression profile (GEP) testing outcomes have positively affected the management decision-making process for cutaneous squamous cell carcinoma (cSCC). Topics covered include most commonly relied upon cancer staging tools, the challenge in choosing a GEP test for further assessing the risk of a lesion under scrutiny, and advice from Dr. Graham Litchman whenever clinicians are starting to incorporate new technologies. |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
